The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVesuvius Regulatory News (VSVS)

Share Price Information for Vesuvius (VSVS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 485.00
Bid: 484.50
Ask: 485.50
Change: 9.00 (1.89%)
Spread: 1.00 (0.206%)
Open: 467.50
High: 486.50
Low: 467.50
Prev. Close: 476.00
VSVS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Declaration

8 Dec 2017 15:30

RNS Number : 8492Y
Vesuvius plc
08 December 2017
 

Vesuvius plc

8 December 2017

 

Notification of Directorship

 

Vesuvius plc announces that Douglas Hurt, the senior independent non-executive director of Vesuvius plc, has been appointed as a non-executive director of Countryside Properties PLC with effect from 1 January 2018.

 

This notification is made in accordance with paragraph 9.6.14R of the Listing Rules.

 

 

---- Ends -----

 

For further information please contact:

 

Henry Knowles, General Counsel and Company Secretary, +44 (0) 20 7822 0000

 

Virginia Skroski, Investor Relations Manager +44 (0) 20 7822 0016

 

Vesuvius plc

165 Fleet Street

London EC4A 2AE

Tel: +44 (0) 20 7822 0000

Fax: +44 (0) 20 7822 0100

Web: www.vesuvius.com

 

About Vesuvius plc

 

Vesuvius is a global leader in molten metal flow engineering principally serving the steel and foundry industries.

 

We develop innovative and customised solutions, often used in extremely demanding industrial environments, which enable our customers to improve their manufacturing processes, enhance product quality and reduce energy consumption. These include flow control solutions, advanced refractories and other consumable products and - increasingly - related technical services including data capture.

 

We have a worldwide presence. We serve our customers through a network of low-cost manufacturing plants located close to their own facilities, and embed our industry experts within their operations, who are all supported by our global technology centres.

 

Our core competitive strengths are our market and technology leadership, strong customer relationships, well established presence in developing markets and our global reach, all of which facilitate the expansion of our addressable markets.

 

Our ultimate goal is to create value for our customers, and to deliver sustainable, profitable growth for our shareholders giving a superior return on their investment whilst providing each of our employees with a safe workplace where he or she is recognised, developed and properly rewarded.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDNOKFDKNBDDABK
Date   Source Headline
8th Mar 202212:38 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSFull Year Results 31 December 2021
7th Feb 202210:05 amRNSHolding(s) in Company
7th Feb 202210:03 amRNSHolding(s) in Company
21st Dec 20215:35 pmRNSVesuvius plc Completes Full Pension Scheme Buy-In
14th Dec 20211:15 pmRNSTotal Voting Rights
6th Dec 20212:32 pmRNSAcquisition Completion-Universal Refractories, Inc
2nd Dec 20212:00 pmRNSAcquisition of Universal Refractories, Inc
11th Nov 20217:00 amRNSTrading Statement
8th Nov 202111:48 amRNSHolding(s) in Company
23rd Sep 20214:05 pmRNSDirector/PDMR Shareholding
10th Aug 202111:38 amRNSHolding(s) in Company
29th Jul 20217:00 amRNSHalf-year Results
10th Jun 20219:32 amRNSHolding(s) in Company
27th May 20215:02 pmRNSDirector/PDMR Shareholding
12th May 20213:52 pmRNSResult of AGM
12th May 20217:00 amRNSAGM Trading Update
4th May 20213:10 pmRNSHolding(s) in Company
4th May 20219:03 amRNSHolding(s) in Company
23rd Apr 20219:12 amRNSHolding(s) in Company
14th Apr 20215:30 pmRNSHolding(s) in Company
12th Apr 20216:00 pmRNSHolding(s) in Company
9th Apr 20215:52 pmRNSHolding(s) in Company
1st Apr 20215:56 pmRNSTotal Voting Rights
1st Apr 20215:52 pmRNSHolding(s) in Company
31st Mar 20216:23 pmRNSAnnual Financial Report
31st Mar 20216:16 pmRNSHolding(s) in Company
31st Mar 20216:15 pmRNSHolding(s) in Company
29th Mar 20216:22 pmRNSHolding(s) in Company
29th Mar 20219:26 amRNSDirectorate Change
26th Mar 20215:54 pmRNSHolding(s) in Company
19th Mar 20215:52 pmRNSDirector/PDMR Shareholding
19th Mar 20215:49 pmRNSDirector/PDMR Shareholding
19th Mar 20213:54 pmRNSHolding(s) in Company
17th Mar 20215:07 pmRNSDirector/PDMR Shareholding
4th Mar 20217:00 amRNSFinal Results
12th Feb 20215:45 pmRNSHolding(s) in Company
17th Dec 202010:51 amRNSChange in Director's Details
11th Dec 202010:57 amRNSDirector/PDMR Shareholding
4th Dec 202010:14 amRNSHolding(s) in Company
30th Nov 20207:00 amRNSDirectorate Change
24th Nov 20203:07 pmRNSHolding(s) in Company
12th Nov 20207:00 amRNSTrading Update
22nd Oct 20209:50 amRNSHolding(s) in Company
20th Oct 20207:00 amRNSDividend Declaration
13th Oct 202011:30 amRNSTotal Voting Rights
6th Oct 202010:42 amRNSHolding(s) in Company
17th Sep 20207:00 amRNSDebt and Liquidity Update
2nd Sep 20208:31 amRNSDirector/PDMR Shareholding
30th Jul 20207:00 amRNSResults for the six months ended 30 June 2020

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.